-
BioLamina AB announces appointment of new management team members
Stockholm August 16, 2023 BioLamina AB BioLamina announces appointment of new management team members BioLamina is pleased to announce the […]
-
BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite
Stockholm May 23rd, 2023 BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite BioLamina announces […]
-
BioLamina AB sets the stage for US expansion by opening office in Boston
Stockholm June 13th, 2022 BioLamina AB sets the stage for US expansion by opening office in Boston BioLamina proudly announces […]
-
BioLamina further Strengthens Leadership by appointing Pia van der Zee as Chief Commercial Officer
Stockholm March 7th, 2022 BioLamina further Strengthens Leadership by appointing Pia van der Zee as Chief Commercial Officer BioLamina is […]
-
BioLamina with partners in the innovation milieu IndiCell receive SEK 40M to establish and propel individualized cell therapy treatments in Sweden
Stockholm October 19th, 2021 BioLamina with partners in the innovation milieu IndiCell receive SEK 40M to establish and propel individualized […]
-
Appointment of new CEO at BioLamina AB
Stockholm September 30th, 2021 Appointment of new CEO at BioLamina AB The Board of Directors of BioLamina is pleased to […]
-
BioLamina AB expands production and office space to meet the fast-growing customer demand
Stockholm September 14th, 2021 BioLamina AB expands production and office space to meet the fast-growing customer demand BioLamina (Stockholm) is […]
-
BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models
Stockholm August 24th, 2021 BioLamina AB and Inventia Life Science partner to advance cell matrices for complex 3D cell models […]
-
BioLamina AB launches new website
June 22, 2021 BioLamina AB launches new website BioLamina (Stockholm) is thrilled to announce the launch of its new website, […]
-
BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of human diseases
June 9, 2021 BioLamina AB and partners granted € 6.1M in funding to develop organ-on-chip system for animal-free modelling of […]